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Membrane targeting by the modern human immunodefi-
ciency viruses is dependent on the plasma membrane-
located phospholipid PI(4,5)P2. In order to determine if
evolutionarily distant retroviruses are targeted by a similar
mechanism, we generated mutant Gag constructs in the
matrix (MA) domain of the Murine Leukemia Virus
(MuLV) and examined their binding to membrane mod-
els and phenotypes in cell culture. Mutations in the MA
polybasic region altered Gag localization, membrane
binding and virion production. In addition, we show that
MA binds with good affinity to all the phosphatidylinosi-
tol phosphates but displays a strong specificity for
PI(4,5)P2 only if enhanced by phophatidylserine. Virus
production was strongly impaired by PI(4,5)P2 depletion
under 5ptaseIV overexpression. Our results suggest that
the N-terminal polybasic region of MA is essential for Gag
targeting to the plasma membrane and Gag cellular traf-
ficking. The binding of the MA domain to PI(4,5)P2
appears to be a conserved feature among retroviruses,
despite the fact that the MuLV-MA domain is structurally
different from that of HIV-1 and -2 and lacks a readily
identifiable PI(4,5)P2 binding cleft.
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